App Logo
Sign Up
← Back to Directory
COMPANY

Sermo

Sermo is a verified clinician network monetised through research, insights and healthcare advertising.

Analyst Perspective

Sermo is a healthcare-focused digital platform built around a verified community of clinicians, especially physicians. It operates a closed professional network where healthcare professionals discuss cases, share treatment experience, access peer-generated content, and participate in paid research. The company monetises this community primarily by selling access to its clinician audience and data to pharmaceutical, biotech, medical device, and healthcare organisations. Its revenue model combines market research services, insight products, analytics, and advertising. Sermo also runs a self-serve ad platform for healthcare marketers seeking targeted access to verified healthcare professionals inside a closed environment. In practice, Sermo functions as a hybrid of a professional social platform, a physician research panel, and a healthcare media and insights business.

Analyst Signal Briefing

Updated: 15 Jul 2026

Sermo continues to expand its healthcare market intelligence, specifically regarding the commercial complexities and prescribing risks within the GLP-1 and weight management sectors. This strategic focus reinforces the organisation’s role in providing physician-led data to address market demand and virtual care challenges. Under the leadership of CEO Peter Kirk, CMO Erin Fitzgerald, and CFO Andy Bray, the company also maintains community engagement via its recurring Run for Research initiative, further solidifying its position as a central hub for professional medical dialogue and actionable industry insights.

Explorer Tier

Start exploring for free

Start with public company intelligence. Save companies, build your first watchlist, and unlock deeper strategic insights when you are ready.

Get Started with Explorer
Free
  • View public Company Profiles
  • Save/watch companies
  • Build your first Watchlist
  • Access additional market signals

Key insights about Sermo

Competitors

Key competitors include WebMD, Doximity, DeepIntent.

View competitors →

Similar Companies

Explore companies with a similar market position and structure.

Explore landscape →

Acquisitions

View companies acquired by Sermo over time.

View acquisitions →

Category Differentiation

Sermo is not an electronic health record, telemedicine provider, or general consumer health forum. It is a verified clinician community and healthcare intelligence platform monetised through research, insights, and advertising.

Sermo: About

Sermo creates value by aggregating and retaining a credential-verified healthcare professional community, then packaging access to that audience in several commercial forms. On one side, clinicians join the platform for peer discussion, content, drug knowledge, and paid participation opportunities. On the other, life sciences and healthcare clients pay for market research, custom insight generation, ongoing sentiment measurement, and targeted media access. This makes Sermo a dual-sided platform whose core asset is trusted access to verified clinicians and the resulting first-party data and engagement environment.

How Sermo Works & Monetises

Business model analysis and core revenue streams

Sermo monetises primarily through B2B revenue streams. These include project-based market research fees for customised surveys and fieldwork, managed-service fees for physician insight and engagement programmes, and campaign-based advertising revenue from marketers using its self-serve and managed media products. The clinician side is generally free to use, with member incentives funded by research demand; this supports supply acquisition, engagement, and data quality. Commercially, the model blends service fees, media spend, and insight product revenue rather than consumer subscription income.

Revenue Channels

Custom physician market researchProject fees for survey design, fielding, sampling, and reporting
Healthcare advertising and campaign activationCampaign-based spend and targeting fees via self-serve and managed media products
Insight reports and analytics productsManaged-service and report-based fees
Ongoing sentiment and measurement productsSubscription or recurring access to tracking outputs

Side-by-Side Comparisons

Compare Sermo directly with top competitors

Sermo vs WebMD→Sermo vs Doximity→Sermo vs DeepIntent→

Products & Services in Categories

Verified structural categorizations from the graph

Sermo: Key Competitors & Alternatives

→ View full competitor landscape

Recent Signals (Sermo)

SermoJul 7, 2026

Online GLP-1 prescribing gaps raise risks for virtual care platforms, marketers

Posted: July 7, 2026 | Emarketer

Read original source
SermoMay 20, 2026

Nutrition care platform Nourish raises $100M on rising demand for GLP-1 support

The article discusses the recent funding raised by Nourish, a nutrition care platform, highlighting the increasing demand for GLP-1 support.

Read original source
SermoMay 14, 2026

Run for Research is back for Year 5! Move with us on June 7 from anywhere. Sign up today.

Read original source

Sermo: Frequently Asked Questions

What is Sermo?

Sermo is a verified healthcare professional network that also sells market research, insight, and advertising access to healthcare and life sciences organisations.

Who uses Sermo?

Clinicians use it for peer discussion, drug knowledge, and paid research participation, while pharma, biotech, medical device, and healthcare organisations use it for research and targeted engagement.

How does Sermo make money?

It makes money mainly from enterprise clients through customised market research, insight products, and healthcare advertising and campaign services.

Company Facts

Founded
2000
Headquarters
9 Crosby St, Floor 2, New York, NY 10013, US
Core Segment
Publisher & Media Owner
Company Size
201–500
Official Link
sermo.com